← Back to Clinical Trials
Recruiting NCT05929820

NCT05929820 Impact of Protect Your Colon™ on CRC Screening

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05929820
Status Recruiting
Phase
Sponsor Cedars-Sinai Medical Center
Condition Colorectal Cancer Screening
Study Type INTERVENTIONAL
Enrollment 184 participants
Start Date 2023-09-28
Primary Completion 2026-06-30

Trial Parameters

Condition Colorectal Cancer Screening
Sponsor Cedars-Sinai Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 184
Sex ALL
Min Age 45 Years
Max Age 75 Years
Start Date 2023-09-28
Completion 2026-06-30
Interventions
Protect Your Colon™

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.

Eligibility Criteria

Inclusion Criteria: * Individuals 45 to 75 years old * No prior CRC screening or not up-to-date with CRC screening * Not at high risk for CRC (e.g., inflammatory bowel disease, colon polyposis syndromes, family history of CRC) * No prior colon polyps * Additional inclusion criteria for participants recruited through Cint online survey panels: (i) appointment with a primary care provider up to 6 weeks from time of screening, and (ii) have Preferred Provider Organization (PPO) insurance. Exclusion Criteria: * Does not speak English * Does not have internet access * Any records flagged "break the glass" or "research opt out."

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology